Post by
askretka on Jan 15, 2021 8:24am
3 shots on goal for 2021
Recent letter to shareholders has all the info in it. CEO James Saperstein previously sold Tobira to Allergen for 1.7 Billion. " NEW YORK (TheStreet) --Shares ofTobira Therapeutics(TBRA)are skyrocketing on heavy trading volume on Tuesday morning by over 700% to $39.24, after it was announced the clinical-stage biopharmaceutical company will be acquired byAllergan(AGN) in a deal valued at up to $1.7 billion." Should have Results in Q1 and Q2 that could move the stock. CEO in letter to shareholders says we have a 3 shots at a billion dollar treatments in 2021. 1.People who get COVID-19 have GI problems. 2. People undergoing Chemotherapy who have GI problems and diarrhea have to get less than optimal dose or stop treatment 22 Billion dollar a year market. 3. Treatment for Cystic Fibrosis patients who have trouble with digestion